A behind-the-scenes look at the most lucrative discipline withinbiotechnology
Bioinformatics represents a new area of opportunity for investorsand industry participants. Companies are spending billions on thepotentially lucrative products that will come from bioinformatics.This book looks at what companies like Merck, Glaxo SmithKlineBeecham, and Celera, and hospitals are doing to maneuver themselvesto leadership positions in this area. Filled with in-depth insightsand surprising revelations, Digital Code of Life examines thepersonalities who have brought bioinformatics to life and exploresthe commercial applications and investment opportunities of themost lucrative discipline within genomics.
Glyn Moody (London, UK) has published numerous articles in Wiredmagazine. He is the author of the critically acclaimed book RebelCode.
Glyn Moody
Bioinformatik Biotechnologie Business & Management Business Technology Finance & Investments Finanz- u. Anlagewesen Unternehmenstechnologie Wirtschaft Wirtschaft u. Management